C07K 11/00
Depsipeptides having up to 20 amino acids in a fully defined sequence
Official title: Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
C07K11/00 (Depsipeptides having up to 20 amino acids in a fully defined sequence) appears on 225 US grants and 255 published applications in this corpus.
Search patents in C07K- Granted patents
- 225
- Published applications
- 255
- Assignees
- 163
- Inventors
- 766
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 6 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 0 | 0 |
| 1996 | 6 | 0 |
| 1997 | 8 | 0 |
| 1998 | 7 | 0 |
| 1999 | 1 | 0 |
| 2000 | 5 | 0 |
| 2001 | 4 | 2 |
| 2002 | 4 | 7 |
| 2003 | 4 | 6 |
| 2004 | 8 | 5 |
| 2005 | 1 | 5 |
| 2006 | 6 | 4 |
| 2007 | 3 | 5 |
| 2008 | 3 | 4 |
| 2009 | 1 | 5 |
| 2010 | 4 | 7 |
| 2011 | 3 | 4 |
| 2012 | 4 | 8 |
| 2013 | 4 | 5 |
| 2014 | 8 | 18 |
| 2015 | 9 | 16 |
| 2016 | 14 | 10 |
| 2017 | 6 | 15 |
| 2018 | 10 | 15 |
| 2019 | 9 | 15 |
| 2020 | 9 | 20 |
| 2021 | 15 | 16 |
| 2022 | 12 | 19 |
| 2023 | 12 | 12 |
| 2024 | 8 | 11 |
| 2025 | 9 | 15 |
| 2026 | 5 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Paenibacillus strain, antifungal compounds, and methods for their use6 Oct 2026US 12,753,207 B2Bayer CropScience AG
- Netrin G1 polypeptides26 May 2026US 12,637,502 B2Institute For Cancer Research
- Compounds for use in viral infections19 May 2026US 12,630,589 B2Pharma Mar, S. A.
- Heterotandem bicyclic peptide complexes21 Apr 2026US 12,606,594 B2BicycleTx Limited
- Bicyclic peptide ligands specific for EphA210 Mar 2026US 12,570,695 B2BicycleTx Limited
- Improving microbial activity17 Sep 2026US 2026/0275269 A1BASF SE
- Antibiotic Vancomycin-Teixobactin Conjugates10 Sep 2026US 2026/0263611 A1The Regents of the University of California
- Heterologous production of the c33–c45 polyketide fragment of anticancer apratoxins in a cyanobacterial host30 Jul 2026US 2026/0218211 A1Smithsonian Institution
- Cilagicin compounds and methods of use thereof9 Jul 2026US 2026/0193295 A1The Rockefeller University
- Novel Cyclodepsipeptides And Cyclopeptides And Their Use In Therapy25 Jun 2026US 2026/0176304 A1Lifemine Therapeutics, Inc.
Most cited
By later US patents
- Lipid conjugates of therapeutic peptides and protease inhibitors130US 5,554,728 ANeXstar Pharmaceuticals, Inc. · 1996
- Synthesis of dolastatin 1576US 5,554,725 AArizona Board of Regents acting on behalf of Arizona State University · 1996
- Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 1569US 4,879,278 AArizona Board of Regents · 1989
- Pharmaceutical compositions containing didemnins66US 5,294,603 AThe Board of Trustees of the University of Illinois · 1994
- Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 1866US 6,239,104 B1Arizona Board of Regents · 2001